Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuichiro Fujinaga

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Pediatric Nephrology (Berlin, Germany)|March 8, 2024
Pre-emptive rituximab administration for discontinuation of steroid-sparing agents in patients with complicated frequently-relapsing or steroid-dependent nephrotic syndromeShuichiro Fujinaga
Pediatric Nephrology (Berlin, Germany)|February 27, 2024
Timing and selection of steroid-sparing agents for children with early-stage steroid-sensitive nephrotic syndromeShuichiro Fujinaga
Indian Pediatrics|June 30, 2015
Acute Kidney Injury Following Plastic Bronchitis Associated with Influenza B Virus in a Child with Nephrotic SyndromeShuichiro Fujinaga, Taichi Hara
Pediatric Nephrology (Berlin, Germany)|September 20, 2022
Long-term prognosis of rituximab-induced hypogammaglobulinemia in children with complicated steroid-dependent nephrotic syndrome: impact of multiple rituximab coursesYuta Onuki, Shuichiro Fujinaga
Clinical and Experimental Nephrology|July 31, 2020
Should rituximab be administered before cyclophosphamide as a first-line steroid-sparing agent to young children with steroid-dependent nephrotic syndrome?Shuichiro Fujinaga, Akira Mizutani
Pediatric Nephrology (Berlin, Germany)|February 7, 2013
Two dosing regimens for steroid therapy in nephrotic syndromeDaishi Hirano, Shuichiro Fujinaga
Pediatric Nephrology (Berlin, Germany)|November 19, 2013
Risk factors for early relapse during maintenance therapy after a single infusion of rituximab in children with steroid-dependent nephrotic syndromeShuichiro Fujinaga, Daishi Hirano
Pediatric Nephrology (Berlin, Germany)|December 17, 2017
Single infusion of low-dose ofatumumab in a child with complicated nephrotic syndrome with anti-rituximab antibodiesShuichiro Fujinaga, Koji Sakuraya
Pediatric Nephrology (Berlin, Germany)|March 18, 2014
Re-treatment with high-dose prednisolone after rituximab infusion for childhood-onset steroid-resistant nephrotic syndromeShuichiro Fujinaga, Taichi Hara
Pediatrics International : Official Journal of the Japan Pediatric Society|March 12, 2022
Impact of methylprednisolone pulse therapy on anthropometric outcomes in children with immunoglobulin A nephropathy and Henoch-Schönlein purpura nephritisShuichiro Fujinaga, Yoichi Takemasa
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Pediatric Nephrology (Berlin, Germany)|March 8, 2024
Pre-emptive rituximab administration for discontinuation of steroid-sparing agents in patients with complicated frequently-relapsing or steroid-dependent nephrotic syndromeShuichiro Fujinaga
Pediatric Nephrology (Berlin, Germany)|February 27, 2024
Timing and selection of steroid-sparing agents for children with early-stage steroid-sensitive nephrotic syndromeShuichiro Fujinaga
Indian Pediatrics|June 30, 2015
Acute Kidney Injury Following Plastic Bronchitis Associated with Influenza B Virus in a Child with Nephrotic SyndromeShuichiro Fujinaga, Taichi Hara
Pediatric Nephrology (Berlin, Germany)|September 20, 2022
Long-term prognosis of rituximab-induced hypogammaglobulinemia in children with complicated steroid-dependent nephrotic syndrome: impact of multiple rituximab coursesYuta Onuki, Shuichiro Fujinaga
Clinical and Experimental Nephrology|July 31, 2020
Should rituximab be administered before cyclophosphamide as a first-line steroid-sparing agent to young children with steroid-dependent nephrotic syndrome?Shuichiro Fujinaga, Akira Mizutani
Pediatric Nephrology (Berlin, Germany)|February 7, 2013
Two dosing regimens for steroid therapy in nephrotic syndromeDaishi Hirano, Shuichiro Fujinaga
Pediatric Nephrology (Berlin, Germany)|November 19, 2013
Risk factors for early relapse during maintenance therapy after a single infusion of rituximab in children with steroid-dependent nephrotic syndromeShuichiro Fujinaga, Daishi Hirano
Pediatric Nephrology (Berlin, Germany)|December 17, 2017
Single infusion of low-dose ofatumumab in a child with complicated nephrotic syndrome with anti-rituximab antibodiesShuichiro Fujinaga, Koji Sakuraya
Pediatric Nephrology (Berlin, Germany)|March 18, 2014
Re-treatment with high-dose prednisolone after rituximab infusion for childhood-onset steroid-resistant nephrotic syndromeShuichiro Fujinaga, Taichi Hara
Pediatrics International : Official Journal of the Japan Pediatric Society|March 12, 2022
Impact of methylprednisolone pulse therapy on anthropometric outcomes in children with immunoglobulin A nephropathy and Henoch-Schönlein purpura nephritisShuichiro Fujinaga, Yoichi Takemasa
Pageof 16